Stock comparison
Guardian Pharmacy Services
LeMaitre Vascular
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
GRDN
Guardian Pharmacy Services
Market cap
$2.44B
Sector
Healthcare
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | GRDN | LMAT | Winner |
|---|---|---|---|
| Warren Buffett | 54C | 77B | LMAT |
| Benjamin Graham | 62D | 89A | LMAT |
| Philip Fisher | 57C | 81C | LMAT |
| Peter Lynch | 60C | 67B | LMAT |
| Joel Greenblatt | 61C | 56D | GRDN |
| Charlie Munger | 47D | 68D | LMAT |
| Terry Smith | 52C | 69D | LMAT |
Side-by-side metrics
| Metric | GRDN | LMAT |
|---|---|---|
| Market cap | $2.44B | $2.23B |
| P/E (TTM) | 42.7x | 37.1x |
| EV/EBIT | 30.8x | 36.6x |
| ROIC (TTM) | 20.71% | 9.43% |
| Gross margin | 20.93% | 72.39% |
| Net margin | 3.64% | 24.35% |
| Revenue CAGR 5y | 16.29% | 12.75% |
| EPS CAGR 5y | 30.79% | 19.04% |
| Debt / Equity | 0.2x | 0.5x |
| Dividend yield | 0.0% | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
GRDN leads on
- Debt / Equity0.2xvs 0.5x+64%
- ROIC (TTM)20.71%vs 9.43%+54%
- EPS CAGR 5y30.79%vs 19.04%+38%
- Revenue CAGR 5y16.29%vs 12.75%+22%
LMAT leads on
- Dividend yield0.84%vs 0.0%+100%
- Net margin24.35%vs 3.64%+85%
- Gross margin72.39%vs 20.93%+71%
- P/E (TTM)37.1xvs 42.7x+13%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.